Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Impel Pharmaceuticals Inc (IMPL)
Impel Pharmaceuticals Inc (IMPL) News

IMPL

Impel Pharmaceuticals (IMPL)

Impel Pharmaceuticals Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IMPL

<< Previous 1 2 3 4 5 Next >>

Date	Time	Source	Headline	Symbol	Company
05/12/2023	11:23AM	Edgar (US Regulatory)	Report of Proposed Sale of Securities (144)	NASDAQ:IMPL	Impel Pharmaceuticals Inc
05/12/2023	8:00AM	GlobeNewswire Inc.	Impel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update	NASDAQ:IMPL	Impel Pharmaceuticals Inc
05/10/2023	8:11AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IMPL	Impel Pharmaceuticals Inc
05/10/2023	8:00AM	GlobeNewswire Inc.	Impel Pharmaceuticals Announces Appointment of Michael W. Kalb as Chief Financial Officer	NASDAQ:IMPL	Impel Pharmaceuticals Inc
05/05/2023	8:00AM	GlobeNewswire Inc.	Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023	NASDAQ:IMPL	Impel Pharmaceuticals Inc
04/27/2023	4:10PM	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:IMPL	Impel Pharmaceuticals Inc
04/27/2023	4:09PM	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:IMPL	Impel Pharmaceuticals Inc
04/26/2023	8:00AM	GlobeNewswire Inc.	Impel Pharmaceuticals Presents New Data at AAN 2023 Suggesting Trudhesa® Nasal Spray is Safe to Use When Co-Administered With Commonly Prescribed Migraine Medications	NASDAQ:IMPL	Impel Pharmaceuticals Inc
04/17/2023	4:35PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IMPL	Impel Pharmaceuticals Inc
04/14/2023	4:59PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMPL	Impel Pharmaceuticals Inc
04/14/2023	4:12PM	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:IMPL	Impel Pharmaceuticals Inc
04/13/2023	6:11PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:IMPL	Impel Pharmaceuticals Inc
04/12/2023	4:07PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IMPL	Impel Pharmaceuticals Inc
04/12/2023	4:01PM	GlobeNewswire Inc.	Impel Pharmaceuticals Announces Appointment of Darren Cline to the Board of Directors	NASDAQ:IMPL	Impel Pharmaceuticals Inc
04/11/2023	8:00AM	GlobeNewswire Inc.	Impel Pharmaceuticals to Present Data on Trudhesa® Nasal Spray for Treatment of Acute Migraine at 2023 American Academy of Neurology Annual Meeting	NASDAQ:IMPL	Impel Pharmaceuticals Inc
03/31/2023	4:32PM	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:IMPL	Impel Pharmaceuticals Inc
03/24/2023	8:22AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IMPL	Impel Pharmaceuticals Inc
03/24/2023	8:17AM	GlobeNewswire Inc.	Impel Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update	NASDAQ:IMPL	Impel Pharmaceuticals Inc
03/17/2023	8:00AM	GlobeNewswire Inc.	Impel Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on Friday, March 24, 2023	NASDAQ:IMPL	Impel Pharmaceuticals Inc
03/10/2023	4:34PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:IMPL	Impel Pharmaceuticals Inc
03/03/2023	4:08PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IMPL	Impel Pharmaceuticals Inc
03/03/2023	4:01PM	GlobeNewswire Inc.	Impel Pharmaceuticals to Participate in Upcoming Investor Conferences in March	NASDAQ:IMPL	Impel Pharmaceuticals Inc
02/22/2023	4:30PM	GlobeNewswire Inc.	Impel Pharmaceuticals Announces Strategic Repriortization, Continues Focus on Maximizing Trudhesa® Commercial Opportunity	NASDAQ:IMPL	Impel Pharmaceuticals Inc
02/16/2023	6:24PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMPL	Impel Pharmaceuticals Inc
02/16/2023	6:24PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMPL	Impel Pharmaceuticals Inc
02/16/2023	6:21PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMPL	Impel Pharmaceuticals Inc
02/16/2023	6:20PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMPL	Impel Pharmaceuticals Inc
01/04/2023	6:46PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMPL	Impel Pharmaceuticals Inc
11/15/2022	3:55PM	TipRanks	JonesTrading Sticks to Their Buy Rating for Impel NeuroPharma Inc (IMPL)	NASDAQ:IMPL	Impel Pharmaceuticals Inc
11/14/2022	4:25PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:IMPL	Impel Pharmaceuticals Inc

Showing the most relevant articles for your search:NASDAQ:IMPL

<< Previous 1 2 3 4 5 Next >>

Ethema Health (PK)

Fannie Mae (QB)

Northwest Biotherapeutics (QB)

Cann American (CE)

Digital Brand Media and ... (PK)

Ronn Motor (PK)

Asia Broadband (PK)

Rennova Health (PK)

Virexit Technologies (PK)

Lightwave Logic

RespireRx Pharmaceuticals (PK)

Brookmount Explorations (PK)

Delayed Upgrade Clock